Get the Stockscreener App
21.48
2.29%
0.48
Pre-market:
21.48
Progyny Inc stock is traded at $21.48, with a volume of 2.17M.
It is up +2.29% in the last 24 hours and up +49.79% over the past month.
Progyny Inc is a company engaged in specializing in fertility and family building benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of the treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments and active management of the selective network of high-quality provider clinics.
See More
Previous Close:
$21.00
Open:
$21.17
24h Volume:
2.17M
Relative Volume:
1.28
Market Cap:
$1.83B
Revenue:
$1.13B
Net Income/Loss:
$62.75M
P/E Ratio:
34.10
EPS:
0.63
Net Cash Flow:
$170.92M
1W Performance:
+7.19%
1M Performance:
+49.79%
6M Performance:
-22.71%
1Y Performance:
-42.58%
1-Day Range:
$21.09
$21.66
1-Week Range:
$19.94
$21.66
52-Week Range:
$13.39
$42.08
Progyny Inc Stock (PGNY) Company Profile
Name
Progyny Inc
Sector
Industry
Phone
212-888-3124
Address
1359 BROADWAY, NEW YORK, NY
Compare PGNY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
21.48 | 1.83B | 1.13B | 62.75M | 170.92M | 0.63 |
|
VEEV
Veeva Systems Inc
|
223.04 | 36.21B | 2.66B | 665.91M | 1.08B | 4.05 |
|
SOLV
Solventum Corp
|
74.02 | 12.79B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
55.52 | 10.37B | 516.85M | 174.11M | 217.38M | 0.87 |
|
HQY
Healthequity Inc
|
104.74 | 9.08B | 1.15B | 96.70M | -161.99M | 1.09 |
|
TEM
Tempus Ai Inc
|
47.64 | 7.50B | 640.44M | -743.28M | -206.93M | -11.29 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-13-24 | Downgrade | Truist | Buy → Hold |
| Sep-19-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Aug-07-24 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Aug-07-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jul-16-24 | Initiated | JMP Securities | Mkt Outperform |
| May-10-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Sep-27-23 | Initiated | Canaccord Genuity | Buy |
| May-22-23 | Initiated | BTIG Research | Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-05-23 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-07-22 | Initiated | Truist | Buy |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Nov-22-21 | Downgrade | Citigroup | Buy → Neutral |
| Sep-30-21 | Initiated | Berenberg | Buy |
| Aug-12-21 | Initiated | Barclays | Overweight |
| Jun-02-21 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Mar-10-21 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Jun-02-20 | Initiated | Guggenheim | Buy |
| Nov-19-19 | Initiated | Citigroup | Buy |
| Nov-19-19 | Initiated | Goldman | Buy |
| Nov-19-19 | Initiated | JP Morgan | Overweight |
| Nov-19-19 | Initiated | Piper Jaffray | Overweight |
| Nov-19-19 | Initiated | SVB Leerink | Outperform |
View All
Progyny Inc Stock (PGNY) Latest News
(PGNY) On The My Stocks Page - Stock Traders Daily
Progyny shares surge 54% after November Fair Value signal flagged undervaluation - MSN
PGNY Stockholders: Robbins LLP is Investigating the Officers and Directors of Progyny, Inc. to Determine if They Breached Fiduciary Duties Owed to Shareholders - Kilgore News Herald
Progyny adds healthcare veteran Debra Morris to board By Investing.com - Investing.com Australia
Progyny appoints Debra Morris as new board member By Investing.com - Investing.com Australia
IVF treatment demand drops after Alabama ruling, and Progyny’s stock tumbles - MSN
Progyny appoints Debra Morris as new board member - MSN
Progyny, Inc Appoints Debra Morris to Its Board of Directors and Compensation Committee - Marketscreener.com
Progyny adds healthcare veteran Debra Morris to board - MSN
Progyny Strengthens Leadership with New Director Appointment - TipRanks
Progyny Appoints Healthcare Veteran Debra Morris to Board of Directors - GlobeNewswire
Rep. Josh Gottheimer Sells Progyny, Inc. (NASDAQ:PGNY) Shares - MarketBeat
Progyny: The Growth Story Remains Intact (NASDAQ:PGNY) - Seeking Alpha
Progyny FY2024 EPS Estimate Increased by Leerink Partnrs - MarketBeat
Progyny sees Q4 results slightly above guidance ranges provided in November - MSN
Leibman Financial Services Inc. Grows Stock Position in Progyny, Inc. (NASDAQ:PGNY) - MarketBeat
Progyny Stock Rises 7% on Improved 4Q Outlook - MarketWatch
Progyny (NASDAQ:PGNY) Shares Gap UpShould You Buy? - MarketBeat
Progyny's premarket value rises 5.8% on improved 4Q forecast By Investing.com - Investing.com Canada
Progyny to Discuss Updated Financial Expectations at Upcoming JP Morgan Healthcare Conference - The Manila Times
Cigna Healthcare Expands Access to Fertility and Family-Building Benefits and Services - Cigna Newsroom
Cigna Healthcare Expands Access to Fertility and Family-Building Benefits and Services – Company Announcement - Financial Times
Progyny Raises Q4 Guidance as Member Activity Strengthens, CEO to Present at JPM Conference - StockTitan
Progyny, Inc.'s (NASDAQ:PGNY) P/E Is Still On The Mark Following 28% Share Price Bounce - Simply Wall St
(PGNY) Investment Report - Stock Traders Daily
Progyny (NASDAQ:PGNY) Trading Up 3.1%Time to Buy? - MarketBeat
Progyny, Inc. (NASDAQ:PGNY) Shares Sold by International Assets Investment Management LLC - MarketBeat
Kuehn Law Encourages Investors of Progyny, Inc. to Contact Law Firm - PR Newswire
Progyny Stock Saw Big Buys From the CEO and a Former CEO - MSN
Brokerages Set Progyny, Inc. (NASDAQ:PGNY) Price Target at $25.00 - MarketBeat
Is Now An Opportune Moment To Examine Progyny, Inc. (NASDAQ:PGNY)? - Simply Wall St
Progyny Stock Saw Big Buys From the CEO, and a Former CEO - Barron's
The Bottom Fishing Club: Progyny Reverses On Heavy Insider Buying (NASDAQ:PGNY) - Seeking Alpha
Progyny CEO & Director Acquires 136% More Stock - Yahoo Finance
Principal Financial Group Inc. Lowers Stake in Progyny, Inc. (NASDAQ:PGNY) - MarketBeat
Progyny (NASDAQ:PGNY) Shares Gap Up on Insider Buying Activity - MarketBeat
Progyny Chief Executive Officer Trades $3.03M In Company Stock - Benzinga
Bullish Move: David Schlanger Shows Confidence, Acquires $2.20M In Progyny Stock - Benzinga
Progyny, Inc. (PGNY): A Bull Case Theory - Insider Monkey
PGNY INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Progyny, Inc. and Encourages Investors to Contact the Firm! - The Eastern Progress Online
Insider Buying: Progyny, Inc. (NASDAQ:PGNY) Chairman Buys 150,000 Shares of Stock - MarketBeat
Progyny, Inc. (NASDAQ:PGNY) CEO Peter Anevski Purchases 209,500 Shares - MarketBeat
Insider Buying: David Schlanger Acquires 150,000 Shares of Progy - GuruFocus.com
Progyny CEO Peter Anevski buys $3 million in shares By Investing.com - Investing.com Nigeria
Progyny Inc Stock (PGNY) Financials Data
Revenue
Net Income
Cash Flow
EPS
7.02%
1.52%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):